Respiratory Care Devices Market To Grow From USD 23.6 Billion In 2025 To USD 33.6 Billion By 2030, At A CAGR Of 7.3% Marketsandmarketstm

(MENAFN- GlobeNewsWire - Nasdaq) Delray Beach, FL, Aug. 31, 2026 (GLOBE NEWSWIRE) -- MarketsandMarketsTM projects the global respiratory care devices market will grow from USD 23.6 billion in 2025 to USD 33.6 billion by 2030, at a CAGR of 7.3% during the forecast period. Market growth is fueled by the increasing global prevalence of respiratory diseases such as asthma, sleep apnea, and chronic obstructive pulmonary disease (COPD), driven by factors including smoking, aging populations, and rising air pollution levels. Increased awareness of respiratory support following significant investments in ventilators, oxygen therapies, and monitoring equipment during the COVID-19 period is also supporting market growth.

Get PDF Brochure - Market Data & Segmentation:

Key Market Highlights

• Market size, 2025: USD 23.6 billion
• Market forecast, 2030: USD 33.6 billion
• Growth rate: CAGR of 7.3% (2025–2030)
• Largest product type segment: Therapeutic devices
• Largest disease indication segment: Chronic Obstructive Pulmonary Disease (COPD)
• Largest regional market: North America
• Fastest-growing region: Asia Pacific, with a CAGR of 8.0%
• Largest end-user segment: Hospitals
• Key players: Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), Masimo (US), Getinge (Sweden), Nonin (US), Apex Medical (Taiwan), OMRON Healthcare, Inc. (Japan), WEINMANN Emergency Medical Technology GmbH + Co. KG (Germany), Löwenstein Medical SE & Co. KG (Germany), Hillrom & Welch Allyn (Baxter) (US), Teleflex Incorporated (Japan), Air Liquide (France), ICU Medical, Inc. (US), AdaptHealth, LLC (US), Hamilton Medical (Switzerland), Medline Industries, LP (US), Allied Medical, LLC (US), Rotech Healthcare Inc. (US), Drive DeVilbiss Healthcare (US), HUM GmbH (Germany), and Nihon Kohden Corporation (Japan).

Why This Market Matters

The increasing incidence of respiratory diseases is one of the prime factors contributing to the growth of the respiratory care devices market. Conditions such as COPD, asthma, sleep apnea, and acute respiratory distress syndrome are becoming more prevalent due to aging populations, rising tobacco consumption, increasing exposure to indoor and outdoor air pollution, and growing respiratory infections. Because these conditions often require respiratory support, monitoring, and long-term or lifelong care, demand continues to increase for ventilators, oxygen concentrators, nebulizers, and CPAP/BiPAP machines.

The market is also benefiting from increasing demand for home-based respiratory care. Technological advances have made respiratory devices smaller, more user-friendly, and energy-efficient, supporting the adoption of portable oxygen concentrators, CPAP/BiPAP devices, and nebulizers. Growing awareness of remote respiratory treatment following COVID-19, the global aging population, and increasing healthcare expenditure are further supporting demand for home care therapeutic devices.

Market Overview

The respiratory care devices market is driven by demographic, medical, and environmental factors. Key market drivers include the increasing prevalence of respiratory diseases, surge in preterm births, growing outbreaks of infectious diseases affecting the respiratory system, rising sleep disorders, increasing focus on improved patient outcomes, and rising R&D investments for medical devices.

The market ecosystem includes manufacturers, distributors, research and product developers, regulatory bodies, and end users. Manufacturers are involved in research, product development, optimization, and product launches, while distributors include third parties and eCommerce sites involved in marketing.

Analyst Perspective

The growing demand for home care therapeutic devices represents a key opportunity for manufacturers and service providers. Chronic respiratory diseases such as COPD, asthma, and sleep apnea require long-term treatment, while home care offers cost-effectiveness, convenience, enhanced patient comfort, and improved compliance. The development of portable oxygen concentrators, CPAP/BiPAP devices, and nebulizers is making respiratory therapy increasingly suitable for household use.

However, low awareness and underdiagnosis of respiratory diseases remain significant challenges, particularly in low- and middle-income countries. Limited healthcare accessibility, insufficient spirometry and sleep-lab infrastructure, delayed diagnosis, and lack of awareness about respiratory health can restrict the adoption of respiratory care devices.

Speak to Our Analyst - Get Custom Insights:

Segment Analysis

By product type, the therapeutic devices segment holds the highest share of the respiratory care devices market during the forecast period. These devices play a critical role in the management and treatment of acute and chronic respiratory illnesses and include high-flow nasal cannula systems, CPAP and BiPAP machines, ventilators, nebulizers, and oxygen concentrators. Increasing demand for long-term home-based respiratory therapy, the global prevalence of chronic illnesses, and rising hospitalizations are supporting this segment.

By disease indication, the COPD segment holds the highest share of the respiratory care devices market during the forecast period. COPD is becoming increasingly prevalent globally, particularly among older populations, creating demand for non-invasive ventilators, oxygen concentrators, nebulizers, and monitoring devices. Smoking, air pollution, and occupational hazards further contribute to the prevalence of COPD.

By end user, the respiratory care devices market is segmented into hospitals, home care settings, ambulatory care centers, and other end users. Hospitals accounted for the largest share of the market in 2024.

Regional Analysis

North America is expected to account for the largest share of the global respiratory care devices market during the forecast period. The region's market is supported by high rates of chronic respiratory diseases, including asthma, sleep apnea, and COPD, as well as an aging population, long histories of smoking, and rising obesity rates. A strong healthcare system and increasing awareness of respiratory health also support early diagnosis and treatment.

Asia Pacific is expected to register the highest CAGR of 8.0% in the respiratory care devices market. A large patient population and expanding medical device manufacturing capabilities make the region attractive for global and local respiratory care device manufacturers. Rising air pollution, increasing prevalence of asthma and COPD, a rapidly expanding geriatric population, urbanization, lifestyle changes, and higher smoking rates are contributing to the growing respiratory disease burden across China, India, and Southeast Asian countries.

Key Industry Trends

• Increasing prevalence of respiratory diseases
• Rising geriatric population
• Increasing air pollution and respiratory infections
• Growing prevalence of sleep disorders
• Surge in preterm births
• Increasing demand for home-based respiratory care
• Adoption of portable respiratory care devices
• Increasing focus on improved patient outcomes
• Rising R&D investments in medical devices
• Increasing adoption of remote monitoring tools
• Growing demand for connected and user-friendly respiratory devices.

Competitive Landscape

The respiratory care devices market is dominated by a mix of multinational healthcare companies and specialized medical technology firms. Koninklijke Philips N.V., Medtronic, and ResMed are considered market leaders due to their broad product portfolios, global distribution networks, and significant R&D investments. Fisher & Paykel Healthcare also holds a strong position, particularly in humidification and ventilatory support systems. Drägerwerk, GE Healthcare, and Masimo are recognized for innovation and strong hospital partnerships.

Companies are primarily focusing on technological innovation, strategic partnerships, geographic expansion, and portfolio diversification to maintain a competitive edge. Philips Healthcare, ResMed, Medtronic, and GE Healthcare are investing in R&D to develop advanced, user-friendly, and portable devices such as non-invasive ventilators, CPAP machines, and smart inhalers that integrate with digital health platforms. Strategic collaborations with hospitals and healthcare providers are also being used to expand customer bases and enhance service delivery.

Related Reports
Respiratory Diagnostics Market
Next-generation Sequencing Market

CONTACT: About MarketsandMarketsTM: MarketsandMarketsTM has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarketsTM is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStoreTM, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit TM.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarketsTM INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA: +1-888-600-6441 Email:... Visit Our Website:

MENAFN31082026004107003653ID1111601816